Social Space - Automotive

The Ford Motor Co. is preparing another version of its famous Mustang pony car to appear more feminine than before. The Mustang is now painted pink to attract more women and at the same time so as

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

to also serve a much worthy cause – help the campaign in fighting breast cancer.

This summer, Ford intends to offer a "Warriors in Pink" trim package for the sports car to attract new buyers to th

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

e Mustang nameplate and help raise money for breast cancer research. Ford Mustang sales have slipped in the recent months. This is why the automaker is improving its campaign to increase the sales

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

of its pony car.

"One of the reasons for this strategy is to keep the buzz up as high as possible," said Ford spokesman Jim Cain, who noted that the Mustang continues to dominate its segment in th

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

e domestic market. In fact, he said Mustang's share of the U.S. sporty coupe market has climbed to more than 50 percent even as its sales have slipped.

The automaker said that details are still be

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ing ironed out however the new version is expected to feature pink stripes on the outside and pink contrast stitching inside. The pony car package is expected to offer a V-6 engine but the purchase

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

rs can choose either a hardtop or a convertible. A couple of colors will be offered by the automaker but pink is not one of them.

Ford will be manufacturing the Mustangs to order. Some of the prof

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

its will be donated to the Susan G. Komen Breast Cancer Foundation. The foundation is the world’s biggest and most progressive network of breast cancer survivors and activists. It has local affilia

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tes in 125 cities and communities. The foundation also has a great number of advocates at the local, state, and federal level.

Breast cancer is a serious threat in today’s time. In the United Stat

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

es, the rate of new cases of breast cancer has increased by a little over one percent annually starting from the 1940s. During 1990s, the rate of new cases of the malady has leveled off. The recent

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

statistics shows a steep rate of decline in new cases in 2003. However, in 2007 alone, an estimated 178,480 new cases of breast cancer will be diagnosed in the US. The figures are now getting more

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

serious that there is already a need to double the efforts and initiate rigorous campaigns to educate the people and to prevent breast cancer at the earliest time. This is the reason why Ford is of

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

fering a helping hand.

The dilemma now of the automaker is the fact that not everyone is amenable to the idea of a Ford Mustang being marketed at women. Analyst Erich Merkle of IRN Inc. which is b

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ased in Grand Rapids said that the Ford Mustang is an iconic brand that is based on a special mix of speed and testosterone. He said Ford should not mess with success. "Is Mustang going to be a sta

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

llion or a gelding?" Merkle quipped. "The cause is admirable, but the Mustang isn't the right choice." Merkle suggested Ford use another vehicle for the cause-oriented program.

Nevertheless, other

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

enthusiasts are showing their support and are now welcoming the move of the automaker. "I think it's a great idea. It's going to add a little class to the car and a little feminine touch," said Au

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

drey Zavodsky of New Boston, who races Mustangs professionally in the Grand Am Coni Series and teaches high-performance driving at the Bondurant Racing School. "A lot of women are buying Mustangs,

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

and I think this is going to appeal to even more women."

At least two other special edition Mustangs are scheduled for release later year, including a new, limited edition Mustang Bullitt. For the

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

2006 and 2007 model years, the Pony Package option is offered with the V6 model. The Mustang option includes Bullitt-style wheels, a unique grille design with fog lamps, bigger tires, upgraded sus

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

pension, distinctive door striping and emblems, rear deck spoiler and other quality parts likened to the Volvo CV joint

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.socialspace.org.ua/article/383211/socialspace-Ford-Prepares-Another-Mustang-With-A-Cause.html">Ford Prepares Another Mustang With A Cause</a>

BB link (for phorums):
[url=http://www.socialspace.org.ua/article/383211/socialspace-Ford-Prepares-Another-Mustang-With-A-Cause.html]Ford Prepares Another Mustang With A Cause[/url]

Adsense is not he only way to make money with a blog. Learn how you can make 10x what you make with Adsense.

Lawsuit Loans which are also known as pre settlement cash advances allow a financially strapped plaintiff to access a portion of their future legal settlement to pay today’s necessary living expenses...

Tags

Links

Social Space - Ford Prepares Another Mustang With A Cause

Related Articles: